-+ 0.00%
-+ 0.00%
-+ 0.00%

Vogenx names board member Richard Gorman as chief commercial officer

PUBT·10/09/2026 12:02:09
Vogenx names board member Richard Gorman as chief commercial officer
  • Vogenx named board member Richard “Rich” Gorman as chief commercial officer, effective Oct. 12, 2026.
  • Gorman will resign from the board and its committees when he joins management; the company plans to seek a new independent director.
  • Role covers commercial operations and corporate strategy, including market development for post-bariatric hypoglycemia and gastroparesis.
  • Gorman is a 30-year life sciences commercial executive who has supported more than 25 launches across U.S. and international markets.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vogenx Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610090800ACCESSWRNAPR_____1234329) on October 09, 2026, and is solely responsible for the information contained therein.